| 摘要 |
A method of treating a patient infected with a lipid encapsulated virus by administering to the patient about 1000 mg to about 5000 mg per day of a nutritional supplement having from about 40 to about 80 wt.% L-lysine, from about 20 to about 50 wt.% butylated hydroxytoluene and from about 1 to about 10 wt.% Echinacea. Administration of the nutritional supplement inhibits ulcer formation resulting from lipid encapsulated virus infections such as herpes simplex I and II infections. |
